BIO vs DOW · rev $2.58B vs P/E 74, rev $42.96B
BIO (BIO) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Dow Inc (DOW) is a chemicals company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
BIO currently screens at market cap $0. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the BIO and DOW stock pages for the full models.
Not investment advice.